Fernando C. Fervenza

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

Brad H. Rovin, Sharon G. Adler, Jonathan Barratt et al. · Kidney International · 2021 · 2.4K citations · Full text

Medicine, Internal Medicine, Nephrology +16

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Brad H. Rovin, Richard Furie, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 1.4K citations

Medicine, Immunology, Pharmacotherapy +16

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

Daniel C. Cattran, Rosanna Coppo, H. Terence Cook et al. · Kidney International · 2009 · 1.2K citations · Full text

Medicine, Nephrology, Pathology +16

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

Ian S.D. Roberts, H. Terence Cook, Stéphan Troyanov et al. · Kidney International · 2009 · 1K citations

Medicine, Nephrology, Pathology +16